DJ Novavax Inc. Stock Underperforms Friday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Novavax Inc. $(NVAX)$ shed 2.94% to $6.94 Friday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index falling 1.30% to 19,406.83 and Dow Jones Industrial Average falling 1.79% to 42,197.79.
Novavax Inc. closed 61.03% short of its 52-week high of $17.81, which the company achieved on July 26th.
The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson $(JNJ)$ rose 0.28% to $157.10, Pfizer Inc. $(PFE)$ fell 1.21% to $24.54, and Merck & Co. Inc. $(MRK)$ fell 0.13% to $81.71.
Trading volume (5.2 M) remained 4.8 million below its 50-day average volume of 9.9 M.
Data source: Dow Jones Market Data, FactSet. Data compiled June 13, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
June 13, 2025 17:28 ET (21:28 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Comments